These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 3781660
1. Hemoperfusion in reduced-time programmes for chronic uremia. Long-term results. Stefoni S, Colì L, Feliciangeli G, Scolari MP, Bonomini V. Int J Artif Organs; 1986 Sep; 9(5):297-300. PubMed ID: 3781660 [Abstract] [Full Text] [Related]
2. Use of combined hemodialysis/hemoperfusion in chronic uremia. Stefoni S, Feliciangeli G, Colì L, Prandini R, Bonomini V. Contrib Nephrol; 1982 Sep; 29():123-32. PubMed ID: 6804167 [Abstract] [Full Text] [Related]
3. Our experience with combined hemodialysis-hemoperfusion treatment in chronic uremia. Splendiani G, Albano V, Tancredi M, Daniele M, Pignatelli F. Biomater Artif Cells Artif Organs; 1987 Sep; 15(1):175-81. PubMed ID: 3449135 [Abstract] [Full Text] [Related]
4. Combined hemodialysis-hemoperfusion treatment reduces the time of substitutive therapy in chronic uremia. Stefoni S, Feliciangeli G, Coli L, Scolari MP, Bonomini V. Int J Artif Organs; 1981 Jul; 4(4):186-91. PubMed ID: 7327760 [Abstract] [Full Text] [Related]
5. Present status of hemoperfusion/hemodialysis in Italy. Bonomini V, Stefoni S, Feliciangeli G, Colì L, Scolari MP, Prandini R, Casciani CU, Taccone Gallucci M, Albertazzi A, Mioli V. Appl Biochem Biotechnol; 1984 Jul; 10():157-66. PubMed ID: 6395806 [Abstract] [Full Text] [Related]
6. Combined hemoperfusion/hemodialysis in the treatment of uremic patients with vascular access problems: case reports. Espinosa-Meléndez E, Bourgouin PA, Chang TM. Int J Artif Organs; 1986 Sep; 9(5):309-12. PubMed ID: 3781661 [No Abstract] [Full Text] [Related]
7. Multicentric experience with combined hemodialysis/hemoperfusion in chronic uremia. Bonomini V, Stefoni S, Casciani CU, Taccone Gallucci M, Albertazzi A, Cappelli P, Mioli V, Boggi R, Mastrangelo F, Rizzelli S. Contrib Nephrol; 1982 Sep; 29():133-42. PubMed ID: 7075212 [Abstract] [Full Text] [Related]
9. Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion. A comparison of efficiency. Weiss LG, Danielson BG, Fellström B, Wikström B. Nephron; 1989 Sep; 51(3):325-9. PubMed ID: 2918944 [Abstract] [Full Text] [Related]
10. Evaluation of a new coated charcoal for hemoperfusion in uremia. Stefoni S, Feliciangeli G, Coli L, Bonomini V. Int J Artif Organs; 1979 Nov; 2(6):320-3. PubMed ID: 511374 [Abstract] [Full Text] [Related]
12. Biocompatibility of charcoal hemoperfusion. Effects of long-term treatment on lymphocyte characteristics and function. Stefoni S, Nanni Costa A, D'Arcangelo GL, Biavati M, Iannelli S, Bonomini V. Int J Artif Organs; 1986 Sep; 9(5):301-4. PubMed ID: 3491055 [Abstract] [Full Text] [Related]
13. Shortened treatment time by combined hemodialysis and hemoperfusion. Bonomini V, Stefoni S, Feliciangeli G, Colì L, Scolari MP, Orsi C, Nanni Costa A, Prandini R, Galanti S. Contrib Nephrol; 1985 Sep; 44():57-64. PubMed ID: 3987293 [No Abstract] [Full Text] [Related]